ECG

Sodium-glucose co-transporter 2 inhibitors – new frontier in the treatment of heart failure

By Syed Ghias Take Home Messages Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are a novel class of oral hypoglycaemic medications which have been shown to be effective…

View More Sodium-glucose co-transporter 2 inhibitors – new frontier in the treatment of heart failure
Visualisation of a 3D bi-ventricular model obtained through segmenting the volumetric image.

Artificial Intelligence, precision phenotyping and risk prediction in cardiomyopathy

By Ahmed El-Medany Presented by Prof O’Regan, MRC Investigator and Consultant Radiologist, Imperial College London The Digital Innovation in Cardiology session at BCS 2021 was…

View More Artificial Intelligence, precision phenotyping and risk prediction in cardiomyopathy
HF events

Depression associated with increased risk of heart failure events and sudden cardiac death in hypertrophic cardiomyopathy

Hu et al sought to investigate the impact of depression on clinical outcomes in individuals with hypertrophic cardiomyopathy (HCM)

View More Depression associated with increased risk of heart failure events and sudden cardiac death in hypertrophic cardiomyopathy

Beyond Diabetes: The Impact of Empagliflozin in Heart Failure with Reduced Ejection Fraction

(Taken from Expert Analysis- ACC) This secondary analysis from the EMPEROR-Reduced trial shows that use of empagliflozin reduces the risk of CV death or HF…

View More Beyond Diabetes: The Impact of Empagliflozin in Heart Failure with Reduced Ejection Fraction